JP Morgan Chase
DERM icon

JP Morgan Chase’s Journey Medical DERM Stock Holding History

JP Morgan Chase’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.2K Buy
8,466
+2,627
+45% +$20.4K ﹤0.01% 6313
2025
Q4 		$45K Buy
5,839
+900
+18% +$7.06K ﹤0.01% 6273
2025
Q3 		$35.2K Sell
4,939
-797
-14% -$5.78K ﹤0.01% 6337
2025
Q2 		$41.2K Buy
+5,736
New +$39.6K ﹤0.01% 5986
2024
Q4 		– Sell
-469
Closed -$2.65K – 7447
2024
Q3 		$2.65K Buy
469
+449
+2,245% +$2.31K ﹤0.01% 6588
2024
Q2 		$113 Buy
20
+5
+33% +$21 ﹤0.01% 6862
2024
Q1 		$55 Sell
15
-97
-87% -$422 ﹤0.01% 7014
2023
Q4 		$645 Buy
112
+105
+1,500% +$468 ﹤0.01% 6894
2023
Q3 		$19 Buy
+7
New +$16 ﹤0.01% 7175

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase's DERM Position: Q1 2026 in Review

JP Morgan Chase increased its Journey Medical (DERM) stake by 45% in Q1 2026, buying an estimated $20.4K and bringing the position to 8,466 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6313.

JP Morgan Chase first reported a position in DERM in Q3 2023 and has held it in 9 quarters since. The position peaked at $45K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • JP Morgan Chase held 8,466 shares of Journey Medical worth $37.2K as of Q1 2026.
  • JP Morgan Chase bought 2,627 Journey Medical shares in Q1 2026, an estimated $20.4K.
  • Journey Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6313 holding.
  • JP Morgan Chase first reported a position in Journey Medical in Q3 2023 and has held it in 9 quarters since.
  • JP Morgan Chase's Journey Medical position peaked at $45K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.